$2.22T
Total marketcap
$70.12B
Total volume
BTC 55.99%     ETH 9.57%
Dominance
Natera

Natera NTRA Stock

$272.89   1.089091%
Add to favorites
Market Cap
$39.08B
LOW - HIGH [24H]
$261.63 - $273.33
VOLUME [24H]
$1.48M
P/E Ratio
0
Earnings per share
-$1.62
ISIN
US6323071042
Price   Prediction

Natera Price Chart

Sorry, that's all we've gotfor now...

Natera NTRA Financial and Trading Overview

Natera stock price 272.89 USD
Previous Close 274.39 USD
Open 275.95 USD
Bid 254.99 USD x 200
Ask 292.86 USD x 200
Day's Range 273.1 - 283.77 USD
52 Week Range 131.81 - 288.04 USD
Volume 1.64M USD
Avg. Volume 1.58M USD
Market Cap 40.37B USD
Beta (5Y Monthly) 1.505
PE Ratio (TTM) N/A
EPS (TTM) -1.62 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 271.24 USD

NTRA Valuation Measures

Enterprise Value 37.81B USD
Trailing P/E N/A
Forward P/E -1321.6262
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 16.140116
Price/Book (mrq) 22.676805
Enterprise Value/Revenue 15.12
Enterprise Value/EBITDA -141.317

Trading Information

Natera Stock Price History

Beta (5Y Monthly) 1.505
52-Week Change 75.68%
S&P500 52-Week Change 20.51%
52 Week High 288.04 USD
52 Week Low 131.81 USD
50-Day Moving Average 224.12 USD
200-Day Moving Average 212.7 USD

NTRA Share Statistics

Avg. Volume (3 month) 1.58M USD
Avg. Daily Volume (10-Days) 1.86M USD
Shares Outstanding 143.22M
Float 139.07M
Short Ratio 3.66
% Held by Insiders 2.98%
% Held by Institutions 95.95%
Shares Short 5.82M
Short % of Float 4.19%
Short % of Shares Outstanding 4.05%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) March 31, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -9.048%
Operating Margin (ttm) -12.39%
Gross Margin 65.06%
EBITDA Margin -10.69%

Management Effectiveness

Return on Assets (ttm) -9.11%
Return on Equity (ttm) -15.018%

Income Statement

Revenue (ttm) 2.5B USD
Revenue Per Share (ttm) 18.07 USD
Quarterly Revenue Growth (yoy) 38.80%
Gross Profit (ttm) 1.63B USD
EBITDA -267576992 USD
Net Income Avi to Common (ttm) -226315008 USD
Diluted EPS (ttm) -1.54
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.09B USD
Total Cash Per Share (mrq) 7.6 USD
Total Debt (mrq) 240.08M USD
Total Debt/Equity (mrq) 13.53 USD
Current Ratio (mrq) 2.959
Book Value Per Share (mrq) 12.429

Cash Flow Statement

Operating Cash Flow (ttm) 211.02M USD
Levered Free Cash Flow (ttm) 136.92M USD

Profile of Natera

Country United States
State TX
City Austin
Address 13011 McCallen Pass
ZIP 78753
Phone 650 980 9190
Website https://www.natera.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 6135

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

Q&A For Natera Stock

What is a current NTRA stock price?

Natera NTRA stock price today per share is 272.89 USD.

How to purchase Natera stock?

You can buy NTRA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Natera?

The stock symbol or ticker of Natera is NTRA.

Which industry does the Natera company belong to?

The Natera industry is Diagnostics & Research.

How many shares does Natera have in circulation?

The max supply of Natera shares is 143.22M.

What is Natera Price to Earnings Ratio (PE Ratio)?

Natera PE Ratio is now.

What was Natera earnings per share over the trailing 12 months (TTM)?

Natera EPS is -1.62 USD over the trailing 12 months.

Which sector does the Natera company belong to?

The Natera sector is Healthcare.

Natera NTRA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 25873.18 USD
-1.55
6.31B USD 25822.1 USD 26139.37 USD 6.31B USD
us US Tech Health Care IXHC US 1254.95 USD
-1.05
1250.11 USD 1262.34 USD
us US Tech Composite Total Return XCMP US 31918 USD
-1.55
31854.98 USD 32246.38 USD
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 4006.39 USD
-1.69
3993.97 USD 4049.67 USD
us US Tech Global Select Market Com NQGS US 12700.6 USD
-1.53
12675.61 USD 12830.27 USD
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD
Select currency